Skip to content

Study · Animal study (in vivo) · rat · 1983

3 results

[Peptide therapy of sleep disorders in neurotic rats].

Aĭrapetiants MG, Gekht K, Oeme P, Kruglikov RI, Kolomeĭtseva IA

Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova1 May 1983Cited by 1 (Europe PMC)

PMID6193658 (opens in a new tab)PepBankPUB-06193658

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In chronically stressed rats, delta sleep peptide increased sleep duration.

    In plain wordsIn stressed rats, delta sleep peptide increased how long the rats slept.

    Outcome
    IncreaseSleep duration
    Study

    ratn: not reported in source

    Chronic stress (neurotic rats)
    Outcome group
    Sleep · Sleep
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Delta sleep peptide increased sleep duration.
    1 context sentence
    Title · context
    [Peptide therapy of sleep disorders in neurotic rats].

Studies that did not test the peptide alone2

In this study, Delta sleep-inducing peptide (DSIP) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Delta sleep-inducing peptide (DSIP).

  1. 02AnimalNot a test of Delta sleep-inducing peptide (DSIP) aloneAnimal study (in vivo)Efficacy outcome

    In chronically stressed rats, a group of treatments (substance P, eledoisin hexopeptide, delta sleep peptide and ethylcrotyl barbiturate) improved behaviour; the abstract does not give a separate delta sleep peptide result.

    In plain wordsIn stressed rats, a group of four treatments, including delta sleep peptide, improved behaviour. The result is not given for delta sleep peptide alone.

    Outcome
    IncreaseBehaviour
    Study

    ratn: not reported in source

    Chronic stress (neurotic rats)
    Outcome group
    Anxiety and mood · Mental health and mood

    Source sentences

    Summary
    Administration of substance P (SP) eledoisin hexopeptide (EH) (250 mcg/kg), 100-200 mcg/kg of delta sleep peptide and 10 mcg/kg of ethylcrotyl barbiturate improved the rats behaviour and sleep parameters.
    1 context sentence
    Title · context
    [Peptide therapy of sleep disorders in neurotic rats].

    In this study, Delta sleep-inducing peptide (DSIP) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Delta sleep-inducing peptide (DSIP).

  2. 03AnimalNot a test of Delta sleep-inducing peptide (DSIP) aloneAnimal study (in vivo)Efficacy outcome

    In chronically stressed rats, a group of treatments (substance P, eledoisin hexopeptide, delta sleep peptide and ethylcrotyl barbiturate) improved sleep parameters; the abstract does not give a separate delta sleep peptide result for this outcome.

    In plain wordsIn stressed rats, a group of four treatments, including delta sleep peptide, improved sleep. The result is not given for delta sleep peptide alone.

    Outcome
    IncreaseSleep parameters
    Study

    ratn: not reported in source

    Chronic stress (neurotic rats)
    Outcome group
    Sleep · Sleep

    Source sentences

    Summary
    Administration of substance P (SP) eledoisin hexopeptide (EH) (250 mcg/kg), 100-200 mcg/kg of delta sleep peptide and 10 mcg/kg of ethylcrotyl barbiturate improved the rats behaviour and sleep parameters.
    1 context sentence
    Title · context
    [Peptide therapy of sleep disorders in neurotic rats].

    In this study, Delta sleep-inducing peptide (DSIP) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Delta sleep-inducing peptide (DSIP).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 17:28 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.